PPP1R3A and atrial fibrillation: Reducing the concentration of PP1 at the SR by ablating its targeting subunit PPP1R3A has been shown to lead to atrial fibrillation (Alsina et al., 2019), which is consistent with a smaller bistable region expected from reducing [PP1] in our model.